The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer

ConclusionPre-treatment semaphorin 3A level can be a prognostic marker for the mCRC patients who were treated with bevacizumab in patients with metastatic colorectal cancer.

http://link.springer.com/10.1007/s12029-019-00263-4

Source: Journal of Gastrointestinal Cancer - June 19, 2019 Category: Cancer & Oncology Source Type: research